2008
DOI: 10.1002/aoc.1465
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, structural characterization and cytotoxic activity of diorganotin(IV) complexes of N‐(5‐halosalicylidene)tryptophane

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

5
17
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
5

Relationship

3
2

Authors

Journals

citations
Cited by 25 publications
(22 citation statements)
references
References 30 publications
5
17
0
Order By: Relevance
“…Complexes 1 , 2 , 3 , 4 all display in vitro activity against A549 and CoLo205, in which the activity of 3 is the best, but their activity is weaker than clinically used cisplatin. This result is similar to that of our previously reported diethyltin analogues Et 2 Sn(5‐Cl‐2‐OC 6 H 3 CHNCH(CH 2 Ind)COO), Et 2 Sn(5‐Br‐2‐OC 6 H 3 CHNCH(CH 2 Ind)COO) and Et 2 Sn(3,5‐Br 2 ‐2‐OC 6 H 2 CHNCH(CH 2 Ind)COO) . Several groups have reported that the dibutyltin and diphenyltin complexes of the Schiff base ligand derived from substituted salicylaldehyde and α‐amino acid have potentially good inhibition activity for some tumor cells, namely MCF‐7, EVSA‐T, WiDr, IGROV, MI9 MEL, A498, H226, HeLa, CoLo205, HCT‐15 and NCI‐522, and the IC 50 values of some of them against the cell lines are less than 0.05 µg ml −1 .…”
Section: Resultssupporting
confidence: 91%
See 3 more Smart Citations
“…Complexes 1 , 2 , 3 , 4 all display in vitro activity against A549 and CoLo205, in which the activity of 3 is the best, but their activity is weaker than clinically used cisplatin. This result is similar to that of our previously reported diethyltin analogues Et 2 Sn(5‐Cl‐2‐OC 6 H 3 CHNCH(CH 2 Ind)COO), Et 2 Sn(5‐Br‐2‐OC 6 H 3 CHNCH(CH 2 Ind)COO) and Et 2 Sn(3,5‐Br 2 ‐2‐OC 6 H 2 CHNCH(CH 2 Ind)COO) . Several groups have reported that the dibutyltin and diphenyltin complexes of the Schiff base ligand derived from substituted salicylaldehyde and α‐amino acid have potentially good inhibition activity for some tumor cells, namely MCF‐7, EVSA‐T, WiDr, IGROV, MI9 MEL, A498, H226, HeLa, CoLo205, HCT‐15 and NCI‐522, and the IC 50 values of some of them against the cell lines are less than 0.05 µg ml −1 .…”
Section: Resultssupporting
confidence: 91%
“…This is quantified by the value of τ (=0.10), which compares with τ = 0.00 for an ideal square pyramid and τ = 1.00 for an ideal trigonal bipyramid . The Sn(1)O(1) (2.2073(19) Å) and Sn(1)O(3) (2.1761(18) Å) bond distances are consistent with those found in the analogues Et 2 Sn(5‐Cl‐2‐OC 6 H 3 CHNCH(CH 2 Ind)COO) (2.1754(15) and 2.1022(16) Å) and Et 2 Sn(3,5‐Br 2 ‐2‐OC 6 H 2 CHNCH(CH 2 Ind)COO) (2.191(5) and 2.142(5) Å) …”
Section: Resultssupporting
confidence: 60%
See 2 more Smart Citations
“…The organotin moiety, the ligand and the number of tin atoms appear to play an important role in determining their cytotoxicity activity 3–5. In order to continue to expand the chemistry and therapeutic potential of the diorganotin(IV) complexes of the ligands, recently we synthesized and characterized some diorganotin(IV) complexes with N ‐(halosalicylidene)‐α‐amino acid 15–18. As a continuation of our work, here we selected N ‐(3,5‐dibromosalicylidene)tryptophane as a ligand, synthesized four new diorganotin complexes, R 2 Sn[3,5‐Br 2 ‐2‐OC 6 H 2 CHNCH(CH 2 Ind)COO] [Ind = 3‐indolyl; R = Et ( 1 ); n ‐Bu ( 2 ); Cy ( 3 ); Ph ( 4 ); Scheme ], and determined their cytotoxic activity.…”
Section: Introductionmentioning
confidence: 99%